Bacterial virulence factors as promising targets for human monoclonal antibodies
Highlights
Superbugs are drug-resistant microbes causing about 700,000 deaths annually, potentially rising to 10 million by 2050. Pseudomonas aeruginosa is a major hospital-acquired multidrug resistant pathogen, especially dangerous for immunocompromised patients. The World Health Organization lists it as a critical priority pathogen, highlighting the urgent need for new drug targets and therapies.
Because of its key role in bacterial infection, the Type III Secretion System (T3SS) represents a major (…)